QUEBEC CITY, Sept. 13, 2017 /CNW Telbec/ - Opsens Inc. ("Opsens" or the "Company") (TSX: OPS) (OTCQX: OPSSF) is proud to announce that it has been invited to present a short film as part of International Medical Film Festival – Quebec in Good Health.
The film features the OptoWire, Opsens' pressure guide wire designed to measure Fractional Flow Reserve ("FFR"). "This is an exceptional showcase for Opsens," said Louis Laflamme, President and CEO of the Company. "Thanks to the benefits it offers, the OptoWire is now used by cardiologists in more than 30 countries," added Laflamme.
Screening of this short feature film will take place on September 15, 2017 at Université Laval. This screening is open to the public as part of the Festival. The video will be available next week on Opsens' website.
About Opsens Inc. (www.opsens.com or www.opsensmedical.com)
Opsens focuses mainly on the measure of FFR in interventional cardiology. Opsens offers an advanced optical-based pressure guidewire (OptoWire) that aims at improving the clinical outcome of patients with coronary artery disease. Opsens is also involved in industrial activities, offering solutions for critical applications, such as the monitoring of oil wells and other demanding industrial applications.
Forward-looking statements contained in this press release involve known and unknown risks, uncertainties and other factors that may cause actual results, performance and achievements of Opsens to be materially different from any future results, performance or achievements expressed or implied by the said forward-looking statements.
Neither TSX nor its Regulation Services Provider (as that term is defined in the policies of the TSX) accepts responsibility for the adequacy or accuracy of this release.
SOURCE OPSENS INC.
For further information: Louis Laflamme, CPA, CA, Chief Executive Officer, 418.781.0333; Robin Villeneuve, CPA, CA, Chief Financial Officer, 418.781.0333